prescription drug costs Archives

American Policy Failures: The Blocking of Affordable Medications from Abroad

Brian RogersJune 4, 20240118 views

The debate over healthcare and drug prices in the United States highlights significant socio-economic disparities. Higher-income individuals often oppose universal healthcare due to concerns over financial responsibility, while lower-income communities and minorities face substantial barriers to accessing healthcare and healthy food, exacerbating chronic health conditions. High medication costs lead to non-adherence, particularly among those with lower incomes and seniors, resulting in unmanaged health issues and increased hospitalizations. Addressing these disparities requires recognizing the broader socio-economic factors and implementing policies that ensure equitable access to healthcare and medications for all Americans.

Systemic Racism in Healthcare: The Cost of High Drug Prices for Communities of Color

Brian RogersJune 4, 20240132 views

The rising cost of prescription drugs in the United States disproportionately impacts Latino, Black, and immigrant communities, exacerbating existing health disparities. These groups, facing higher rates of chronic conditions and economic barriers, often struggle with affordability and access to necessary medications. Economic instability and lack of insurance further complicate their healthcare access, leading to unmanaged health conditions and increased hospitalizations. Addressing this issue requires comprehensive policy changes, such as allowing Medicare to negotiate drug prices and increasing funding for community health centers, to ensure equitable access to affordable healthcare for all.

Prescription Drug Affordability: A Growing Barrier to Medication Adherence

Brian RogersJune 4, 20240135 views

Medication non-adherence is a major public health issue in the U.S., with high medication costs being a primary driver. This issue leads to preventable hospitalizations and complications, particularly affecting seniors. Projections indicate that without reforms, non-adherence rates could reach 80% in fifteen years, highlighting the need for comprehensive solutions to improve medication affordability and access.